PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 87 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $791,000 | -95.5% | 100,000 | -86.6% | 0.07% | -95.1% |
Q1 2022 | $17,699,000 | -33.9% | 747,441 | -4.5% | 1.34% | -14.1% |
Q4 2021 | $26,774,000 | +407.6% | 782,857 | +163.0% | 1.56% | +401.3% |
Q3 2021 | $5,275,000 | -73.8% | 297,709 | -33.7% | 0.31% | -73.1% |
Q2 2021 | $20,155,000 | +18.8% | 449,082 | -31.4% | 1.16% | +13.9% |
Q1 2021 | $16,962,000 | +142.5% | 654,900 | +83.1% | 1.02% | +96.5% |
Q3 2020 | $6,994,000 | +21.5% | 357,769 | +9.7% | 0.52% | +43.0% |
Q2 2020 | $5,758,000 | – | 326,064 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |